ProQR Therapeutics BV (PRQR) — Long-term Investment Intensity

Latest as of June 2023: 0.4%

ProQR Therapeutics BV (PRQR) has a Long-term Investment Intensity of 0.4% as of June 2023. Long-term investments of $621.00K represent 0.4% of total assets of $147.99 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check PRQR capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

0.4%
LT Investments / Total Assets

Long-term Investments

$621.00K
USD

Total Assets

$147.99 Million
USD

Country

USA
NASDAQ

ProQR Therapeutics BV Long-term Investment Intensity (2019–2022)

This chart shows how ProQR Therapeutics BV's Long-term Investment Intensity has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the intensity stands at 0.4%, reflecting long-term investments of $621.00K against total assets of $147.99 Million USD. Explore ProQR Therapeutics BV debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for ProQR Therapeutics BV (2019–2022)

The table below presents the year-by-year Long-term Investment Intensity for ProQR Therapeutics BV from 2019 to 2022, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of ProQR Therapeutics BV.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2022 0.4% $621.00K $171.32 Million ▲ +0.1 pp
2021 0.3% $629.00K $209.58 Million ▲ +0.2 pp
2020 0.1% $107.00K $120.80 Million ▼ -0.2 pp
2019 0.3% $429.00K $131.93 Million
pp = percentage points